GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prostatype Genomics AB (OSTO:PROGEN) » Definitions » 5-Year Yield-on-Cost %

Prostatype Genomics AB (OSTO:PROGEN) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 11, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Prostatype Genomics AB 5-Year Yield-on-Cost %?

Prostatype Genomics AB's yield on cost for the quarter that ended in Jun. 2023 was 0.00.


The historical rank and industry rank for Prostatype Genomics AB's 5-Year Yield-on-Cost % or its related term are showing as below:



OSTO:PROGEN's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.21
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Prostatype Genomics AB's 5-Year Yield-on-Cost %

For the Diagnostics & Research subindustry, Prostatype Genomics AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prostatype Genomics AB's 5-Year Yield-on-Cost % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Prostatype Genomics AB's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Prostatype Genomics AB's 5-Year Yield-on-Cost % falls into.



Prostatype Genomics AB 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Prostatype Genomics AB is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Prostatype Genomics AB  (OSTO:PROGEN) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Prostatype Genomics AB 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Prostatype Genomics AB (OSTO:PROGEN) Business Description

Traded in Other Exchanges
Address
Gustaf III:s Boulevard 34, Solna, SWE, 169 73
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of prostate cancer can be minimized, the quality of life for the patient improved and money can be saved for the health care sector.

Prostatype Genomics AB (OSTO:PROGEN) Headlines

No Headlines